BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24461722)

  • 21. AsialoGM1 and TLR5 cooperate in flagellin-induced nucleotide signaling to activate Erk1/2.
    McNamara N; Gallup M; Sucher A; Maltseva I; McKemy D; Basbaum C
    Am J Respir Cell Mol Biol; 2006 Jun; 34(6):653-60. PubMed ID: 16439799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional characterisation of bovine TLR5 indicates species-specific recognition of flagellin.
    Metcalfe HJ; La Ragione RM; Smith DG; Werling D
    Vet Immunol Immunopathol; 2014 Feb; 157(3-4):197-205. PubMed ID: 24461722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional analysis of bovine TLR5 and association with IgA responses of cattle following systemic immunisation with H7 flagella.
    Tahoun A; Jensen K; Corripio-Miyar Y; McAteer SP; Corbishley A; Mahajan A; Brown H; Frew D; Aumeunier A; Smith DG; McNeilly TN; Glass EJ; Gally DL
    Vet Res; 2015 Feb; 46():9. PubMed ID: 25827709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characterization of chicken TLR5 reveals species-specific recognition of flagellin.
    Keestra AM; de Zoete MR; van Aubel RA; van Putten JP
    Mol Immunol; 2008 Mar; 45(5):1298-307. PubMed ID: 17964652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells.
    Tallant T; Deb A; Kar N; Lupica J; de Veer MJ; DiDonato JA
    BMC Microbiol; 2004 Aug; 4():33. PubMed ID: 15324458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replacement of two aminoacids in the bovine Toll-like receptor 5 TIR domain with their human counterparts partially restores functional response to flagellin.
    Osvaldova A; Woodman S; Patterson N; Offord V; Mwangi D; Gibson AJ; Matiasovic J; Werling D
    Dev Comp Immunol; 2014 Nov; 47(1):90-4. PubMed ID: 25020193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial flagellin induces IL-6 expression in human basophils.
    Jeon JH; Ahn KB; Kim SK; Im J; Yun CH; Han SH
    Mol Immunol; 2015 May; 65(1):168-76. PubMed ID: 25660969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired TLR5 functionality is associated with survival in melioidosis.
    West TE; Chantratita N; Chierakul W; Limmathurotsakul D; Wuthiekanun V; Myers ND; Emond MJ; Wurfel MM; Hawn TR; Peacock SJ; Skerrett SJ
    J Immunol; 2013 Apr; 190(7):3373-9. PubMed ID: 23447684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adaptive evolution of Toll-like receptor 5 in domesticated mammals.
    Smith SA; Jann OC; Haig D; Russell GC; Werling D; Glass EJ; Emes RD
    BMC Evol Biol; 2012 Jul; 12():122. PubMed ID: 22827462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The structure of the TLR5-flagellin complex: a new mode of pathogen detection, conserved receptor dimerization for signaling.
    Lu J; Sun PD
    Sci Signal; 2012 Mar; 5(216):pe11. PubMed ID: 22434932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis of TLR5-flagellin recognition and signaling.
    Yoon SI; Kurnasov O; Natarajan V; Hong M; Gudkov AV; Osterman AL; Wilson IA
    Science; 2012 Feb; 335(6070):859-64. PubMed ID: 22344444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repertoire of Escherichia coli agonists sensed by innate immunity receptors of the bovine udder and mammary epithelial cells.
    Porcherie A; Cunha P; Trotereau A; Roussel P; Gilbert FB; Rainard P; Germon P
    Vet Res; 2012 Feb; 43(1):14. PubMed ID: 22330199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signatures of positive selection in Toll-like receptor (TLR) genes in mammals.
    Areal H; Abrantes J; Esteves PJ
    BMC Evol Biol; 2011 Dec; 11():368. PubMed ID: 22185391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disparities in TLR5 expression and responsiveness to flagellin in equine neutrophils and mononuclear phagocytes.
    Kwon S; Gewirtz AT; Hurley DJ; Robertson TP; Moore JN; Vandenplas ML
    J Immunol; 2011 Jun; 186(11):6263-70. PubMed ID: 21518971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis.
    Blohmke CJ; Park J; Hirschfeld AF; Victor RE; Schneiderman J; Stefanowicz D; Chilvers MA; Durie PR; Corey M; Zielenski J; Dorfman R; Sandford AJ; Daley D; Turvey SE
    J Immunol; 2010 Dec; 185(12):7731-8. PubMed ID: 21068401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptors in domestic animals.
    Jungi TW; Farhat K; Burgener IA; Werling D
    Cell Tissue Res; 2011 Jan; 343(1):107-20. PubMed ID: 20927536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production and characterization of two monoclonal antibodies to bovine tumour necrosis factor alpha (TNF-alpha) and their cross-reactivity with ovine TNF-alpha.
    Kwong LS; Thom M; Sopp P; Rocchi M; Wattegedera S; Entrican G; Hope JC
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):320-4. PubMed ID: 20207016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flagellin expression enhances Salmonella accumulation in TLR5-positive macrophages.
    Metcalfe HJ; Best A; Kanellos T; La Ragione RM; Werling D
    Dev Comp Immunol; 2010 Aug; 34(8):797-804. PubMed ID: 20188752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense.
    Barreiro LB; Ben-Ali M; Quach H; Laval G; Patin E; Pickrell JK; Bouchier C; Tichit M; Neyrolles O; Gicquel B; Kidd JR; Kidd KK; Alcaïs A; Ragimbeau J; Pellegrini S; Abel L; Casanova JL; Quintana-Murci L
    PLoS Genet; 2009 Jul; 5(7):e1000562. PubMed ID: 19609346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A history of recurrent positive selection at the toll-like receptor 5 in primates.
    Wlasiuk G; Khan S; Switzer WM; Nachman MW
    Mol Biol Evol; 2009 Apr; 26(4):937-49. PubMed ID: 19179655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.